British journal of pharmacology

β-Nicotinamide mononucleotide reduces liver damage from aflatoxin B1 through gut bacteria, bile acids, and the FXR receptor

Updated

Abstract

Aflatoxin B1 (AFB1) is a potent hepatotoxin linked to health risks in livestock and humans.

  • AFB1 exposure is associated with significant liver damage.
  • Beta-Nicotinamide mononucleotide (NMN) may offer therapeutic benefits for liver diseases.
  • The exact mechanism by which NMN protects against AFB1-induced liver injury is not yet understood.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free